SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

4 h delay

Buys Sells Buys and sells Any size $100K+$1M+

Pro filters

NEOSell

NEOGENOMICS INC

Greg D Aunan · Chief Accounting Officer

$321K−79.5%Aug 6

NEOSell

NEOGENOMICS INC

Lynn A. Tetrault · Director

$59K−5.8%Jun 17

NEOSell

NEOGENOMICS INC

Lynn A. Tetrault · Director

$60K−5.5%Jun 11

NEOSell

Neogenomics Inc

Warren Stone · President and COO

$277K−15.0%Jan 21

NEOSell

Neogenomics Inc

Alicia C Olivo · EVP, GC, Business Development

$251K−40.0%Nov 28

NEOSell

Neogenomics Inc

Alicia C Olivo · General Counsel

$79K−12.0%Nov 19

NEOSell

Neogenomics Inc

Lynn A. Tetrault · Director

$98K−11.0%Mar 6

NEOSell

Neogenomics Inc

Alicia C Olivo · General Counsel

$39K−7.0%Feb 20

NEOSell

Neogenomics Inc

Alicia C Olivo · General Counsel

$49K−7.0%Nov 20

NEOSell

Neogenomics Inc

William Bonello · CFO

$59K−3.0%Mar 9

NEOSell

Neogenomics Inc

Kathryn B Mckenzie · CFO

$65K−10.0%Dec 23

NEOSell

Neogenomics Inc

William Bonello · Pres, Informatics

$928K−62.0%Nov 29

NEOSell

Neogenomics Inc

Douglas Matthew Brown · Chief Strategy Officer

$3.7M−90.0%Nov 26

NEOSell

Neogenomics Inc

Bruce K Crowther · Director

$860K−29.0%Jun 10

NEOSell

Neogenomics Inc

George Cardoza · Pres, Pharma Services

$8.1M−50.0%Jun 4

NEOSell

Neogenomics Inc

Robert J. Shovlin · Pres, Clinical Services

$5.1M−47.0%May 27

NEOSell

Neogenomics Inc

Lawrence Martin Weiss · Chief Medical Officer

$1.0M−17.0%Dec 15

NEOSell

Neogenomics Inc

Steven C Jones · Director

$3.6M−5.0%Dec 14

NEOSell

Neogenomics Inc

Jennifer Balliet · VP and Chief Culture Officer

$750K−38.0%Dec 11

NEOSell

Neogenomics Inc

Steven C Jones · Director

$6.3M−9.0%Dec 7

NEOSell

Neogenomics Inc

Kevin C Johnson · Director

$1.2M−44.0%Dec 7

NEOSell

Neogenomics Inc

William Bonello · Pres, Informatics

$374K−40.0%Dec 4

NEOSell

Neogenomics Inc

George Cardoza · Pres, Pharma Services

$5.9M−25.0%Nov 25

NEOSell

Neogenomics Inc

Raymond R Hipp · Director

$3.0M−51.0%Nov 18

NEOSell

Neogenomics Inc

Oort Douglas M Van · Chair and CEO

$14.3M−12.0%Nov 16

NEOSell

Neogenomics Inc

Denise E Pedulla · General Counsel

$95K−4.0%Nov 12

NEOSell

Neogenomics Inc

Steven C Jones · Director

$10.3M−16.0%Sep 30

NEOSell

Neogenomics Inc

Bruce K Crowther · Director

$377K−19.0%Sep 24

NEOSell

Neogenomics Inc

Steven C Jones · Director

$4.4M−6.0%Sep 10

NEOSell

Neogenomics Inc

George Cardoza · Pres, Pharma Services

$3.2M−18.0%Aug 10

NEOSell

Neogenomics Inc

William Bonello · Pres, Informatics

$849K−65.0%Aug 4

NEOSell

Neogenomics Inc

Jennifer Balliet · VP and Chief Culture Officer

$510K−34.0%Aug 4

NEOSell

Neogenomics Inc

Robert J. Shovlin · Pres, Clinical Services

$3.1M−35.0%Aug 3

NEOSell

Neogenomics Inc

Robert J. Shovlin · Pres, Clinical Services

$3.0M−39.0%Mar 5

NEOSell

Neogenomics Inc

Steven C Jones · Director

$8.6M−14.0%Mar 4

NEOSell

Neogenomics Inc

Kathryn B Mckenzie · Chief Accounting Officer

$211K−78.0%Dec 12

NEOSell

Neogenomics Inc

Steven C Jones · Director

$3.7M−8.0%Nov 22

NEOSell

Neogenomics Inc

Oort Douglas M Van · Chair and CEO

$4.5M−8.0%Nov 21

NEOSell

Neogenomics Inc

Jennifer Balliet · VP and Chief Culture Officer

$160K−23.0%Nov 18

NEOSell

Neogenomics Inc

George Cardoza · Pres, Pharma Services

$450K−6.0%Nov 14

NEOSell

Neogenomics Inc

George Cardoza · Pres, Pharma Services

$1.3M−16.0%Nov 8

NEOSell

Neogenomics Inc

Robert J. Shovlin · Pres, Clinical Services

$2.4M−42.0%Nov 4

NEOSell

Neogenomics Inc

Steven C Jones · Director

$68KSep 10

NEOSell

Neogenomics Inc

William Bonello · Chief Strategy Officer

$422K−72.0%Aug 30

NEOSell

Neogenomics Inc

Steven C Jones · Director

$1.0M−2.0%Aug 30

NEOSell

Neogenomics Inc

Raymond R Hipp · Director

$397K−11.0%Aug 27

NEOSell

Neogenomics Inc

Kevin C Johnson · Director

$1.3M−65.0%Aug 27

NEOSell

Neogenomics Inc

Steven C Jones · Director

$4.5M−8.0%Aug 27

NEOSell

Neogenomics Inc

Raymond R Hipp · Director

$3.4M−52.0%May 9

NEOSell

Neogenomics Inc

William Bonello · Chief Strategy Officer

$169K−52.0%May 8

Older filings

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.